Sign in to view content

First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability

Pravin U. Dugel, MD

Video
Published 2019

Pravin U. Dugel, MD

AMD Neovascular Part II Symposium

Related

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
Episode 13: Long-Term Treatment of Wet AMD by 50+ Anti-VEGF Injections with Dr. Sean Adrean
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Previous Intravitreal Therapy is Associated With Increased Risk of Posterior Capsule Rupture During Cataract Surgery
Aaron Y Lee, MD, MSCI
Updates from the Field
2016

Category: AMD-Neovascular

See more